Liver disease (NAFLD/alcoholic)
Appearance
Non-Alcoholic Fatty Liver Disease (NAFLD)
[edit | edit source]- Most common cause of primary chronic liver disease - 25% prevalence in western countries
- Definition:
- Hepatic steatosis in the absence of competing liver disease aetiologies (alcohol, genetic, iatrogenic)
- Pathologically, it's excessive triglyceride accumulation in hepatocytes
- NASH (non-alcoholic steatohepatitis) is a phase of NAFLD: steatosis + lobular inflammation + hepatocyte injury
- Risk factors
- Metabolic syndrome
- Pancreaticoduodenectomy (7-40%) - likely caused by the subsequent exocrine pancreatic insufficiency
- Investigation
- Mild raised transaminases and often mild raised GGT
- USS shows fatty infiltration with no other cause for abnormal results
- CT can show hepatic fatty infiltration, and intra-abdominal fat deposition
- Liver will be hypodense with fatty infiltration - either <40HU, or 10 HU or more less dense than spleen
- Remember can be irregular - 'focal sparing' - especially segment IV
- Liver biopsy is typically not necessary
- Viral serology should be used to exclude other causes
- Management
- Weight loss and exercise, which can improve insulin sensitivity and then improve liver function
- Good diabetic control and management of hyperlipidaemia
- Bariatric surgery works
- Consequences/complications:
- Cirrhosis
- Progression occurs in the presence of non-alcoholic steatohepatitis
- Insulin resistance is likely to be the main driving force if this happens
- HCC (can develop in absence of cirrhosis)
- Donor ineligibility - no precise guidelines on what level of steatosis/fibrosis is and isn't ok
- Cirrhosis
Alcoholic liver disease
[edit | edit source]- Classification
- Fatty liver (reversible)
- Alcoholic hepatitis
- Active inflammatory injury to the liver
- Presentation
- Mild fever
- Jaundice
- Neutrophil leucocytosis
- Moderate raised transaminases (usually <300)
- Tender hepatomegaly
- cirrhosis